Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $39.74 USD
Change Today -0.87 / -2.15%
Volume 1.9M
GSK On Other Exchanges
Symbol
Exchange
OTC US
New York
Xetra
London
Mexico
Frankfurt
As of 3:33 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for glaxosmithkline plc-spon adr (GSK)

Year over year, GlaxoSmithKline plc has seen revenues fall from 26.5B GBP to 23.0B GBP. This along with an increase in SGA costs has led to a reduction in the bottom line from 5.4B GBP to 2.8B GBP.
View Income Statement In U.S. Dollar
Currency in
Millions of British Pounds
As of:Dec 31
2011
Restated
GBP
Dec 31
2012
Restated
GBP
Dec 31
2013
GBP
Dec 31
2014
GBP
4 Year
Trend
Revenues27,387.026,431.026,505.023,006.0
TOTAL REVENUES27,387.026,431.026,505.023,006.0
Cost of Goods Sold7,673.08,051.08,023.07,117.0
GROSS PROFIT19,714.018,380.018,482.015,889.0
Selling General & Admin Expenses, Total8,547.08,789.07,922.07,261.0
R&D Expenses4,020.03,979.03,553.03,262.0
Other Operating Expenses-333.0-339.0-381.0-6.0
OTHER OPERATING EXPENSES, TOTAL12,234.012,429.011,094.010,517.0
OPERATING INCOME7,480.05,951.07,388.05,372.0
Interest Expense-745.0-746.0-727.0-683.0
Interest and Investment Income85.073.059.066.0
NET INTEREST EXPENSE-660.0-673.0-668.0-617.0
Income (Loss) on Equity Investments15.029.043.030.0
Other Non-Operating Income (Expenses)-54.0-60.0-38.0-42.0
EBT, EXCLUDING UNUSUAL ITEMS6,781.05,247.06,725.04,743.0
Merger & Restructuring Charges-----517.0-750.0
Impairment of Goodwill--124.0----
Gain (Loss) on Sale of Investments522.0253.0250.0130.0
Gain (Loss) on Sale of Assets322.0661.01,413.0244.0
Other Unusual Items, Total--315.0-1,224.0-1,399.0
Legal Settlements-----252.0-548.0
Other Unusual Items--189.0-251.0-770.0
EBT, INCLUDING UNUSUAL ITEMS7,625.06,600.06,647.02,968.0
Income Tax Expense2,220.01,922.01,019.0137.0
Minority Interest in Earnings-197.0-179.0-192.0-75.0
Earnings from Continuing Operations5,405.04,678.05,628.02,831.0
NET INCOME5,208.04,499.05,436.02,756.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS5,208.04,499.05,436.02,756.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS5,208.04,499.05,436.02,756.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:US $39.76 USD -0.86

GSK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $59.64 USD -1.94
Bristol-Myers Squibb Co $57.24 USD -1.51
Celgene Corp $117.46 USD -0.19
Eli Lilly & Co $80.23 USD -1.37
Medtronic PLC $69.07 USD -0.91
View Industry Companies
 

Industry Analysis

GSK

Industry Average

Valuation GSK Industry Range
Price/Earnings 6.5x
Price/Sales 2.7x
Price/Book 9.1x
Price/Cash Flow 6.5x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.